Plunkett Research Online: Vectura Group plc

VECTURA GROUP PLC (VEGPF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Vectura Group plc is engaged in the development of inhaled pharmaceuticals, creating products to treat respiratory and lung-related diseases using innovative technologies and expertise. The firm’s development operations are located in Chippenham and Cambridge (U.K.), Muttenz (Switzerland) and Gauti.....



Vectura Group plc
Ticker: VEGPF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 44 1249667700
Fax: 44 1249667701
Address: One Prospect West
Chippenham, Wiltshire SN14 6FH United Kingdom

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
James Ward-LilleyCEO/Director
Andrew DerodraCFO/Director
See More
Vectura Group plc is engaged in the development of inhaled pharmaceuticals, creating products to treat respiratory and lung-related diseases using innovative technologies and expertise. The firm’s development operations are located in Chippenham and Cambridge (U.K.), Muttenz (Switzerland) and Gauti.....See More See More

Auditor: KPMG
Legal Advisor: Clifford Chance
$USD, In whole numbers,
except marked * or %
201720162016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Flutiform
QVM149
VR475
VR315
VR632
VR410
NameTitleSalary (GBP)Bonus (GBP)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: